A Study Exploring the Safety and Tolerability of INCB081776 in Participants With Advanced Malignancies
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Diane Hershock, MD
Incyte Corporation
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Rigshospitalet Uni of Hospital of Copenhagen
Copenhagen, Denmark
- Odense University Hospital
Odense C, Denmark
- Netherlands Cancer Institute Antoni Van Leeuwenhoek Ziekenhuis
Amsterdam, Netherlands
- University Medical Center Groningen
Groningen, Netherlands
- Erasmus Medical Center
Rotterdam, Netherlands
- Haukeland University Hospital
Bergen, Norway
- Utprøvingsenheten, Oslo University Hospital Radiumhospitalet
Oslo, Norway
- Skane University Hospital Lund
Lund, Sweden
- Karolinska University Hospital Solna
Stockholm, Sweden
- Yale Cancer Center
New Haven, Connecticut, United States
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- University of Pennsylvania Abramson Cancer Center
Philadelphia, Pennsylvania, United States
- University of Pittsburgh
Pittsburgh, Pennsylvania, United States
- Sarah Cannon Research Institute
Nashville, Tennessee, United States
- Md Anderson Cancer Center
Houston, Texas, United States
- University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 27 Aug 2018
- Primary completion
- 10 Sept 2025
- Completion
- 10 Sept 2025
- Last update posted
- 9 Oct 2025
- Registered enrollment
- 83
- Registry id
- NCT03522142
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.